Amtolmetin Guacil is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in conditions like osteoarthritis and rheumatoid arthritis, and it works by inhibiting cyclooxygenase (COX) enzymes to reduce prostaglandin production; at the same time, it has a unique advantage over many traditional NSAIDs because it offers better gastrointestinal protection, which is thought to be due to its ability to enhance gastric mucosal defense mechanisms such as nitric oxide release. It was developed as a safer derivative of Tolmetin, an older NSAID known for effectiveness but also for causing gastric side effects, and through chemical modification researchers created amtolmetin guacil as a prodrug that could maintain anti-inflammatory action while minimizing stomach damage; introduced in the late 20th century, it has since been used in several countries with clinical studies supporting its comparable efficacy and improved safety profile for long-term inflammatory conditions.
